Form 4 for INDP Indaptus Therapeutics, Inc.
Accepted 2026-01-22 00:00:00 ET · period of report 2025-12-23 · accession 0001493152-26-003293 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-22 | 2026-01-20 | INDP | Ben-Tzvi Avraham | Dir | A - Grant | $0.00 | +25.0K | 25.1K | +25,000% | $0 |
| D | 2026-01-22 | 2025-12-23 | INDP | Ben-Tzvi Avraham | Dir | A - Grant | $0.00 | +25.0K | 25.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-20 | A | A | 25,000 | $0.00 | 25,100 | D | — | — | (F1) The Reporting Person acquired 25,000 shares of restricted common stock of the Issuer pursuant to a consulting agreement dated January 20, 2026, which shares vested 100% upon grant. (F2) Includes 100 shares of common stock of the Issuer held in a Roth IRA. |
| 2 | Derivative | Option to Buy Common Stock | 2025-12-23 | A | A | 25,000 | $0.00 | 25,000 | D | $1.95 · — to 2035-12-23 | 25,000 Common Stock | (F3) The Reporting Person acquired options to purchase 25,000 shares of common stock pursuant to the Issuer's non-employee director compensation program. The stock options vest over three years commencing from the date of grant in equal quarterly installments subject to continued service on the Board through each vesting date. |